Differences in psoriatic arthritis symptoms are evident between patients with and without hyperuricemia. Endovascular interventional procedures significantly increase the risk of gout flares in the postsurgical period. Utilizing DECT showed that achieving a lower serum urate of <5.0 mg/dL leads to more extensive dissolution of MSU ... Autoimmune hypothyroidism and autoimmune hyperthyroidism have a causal association with an increased risk of gout. A recent study showed that patients with gout, CVD, CKD, and cancer had the highest risk of gout flares. Gout significantly increases the risk of all-cause mortality and mortality due to specific causes. Metformin use was associated with reduced urate levels and a decreased risk of hyperuricemia. Patients with chronic inflammatory diseases face a significantly increased risk of developing post-thrombotic syndrome. Patient characteristics significantly impact serum urate goal achievement during urate-lowering therapy. Examining the potential benefits of pegloticase treatment in patients with CKD with refractory gout. Blood pressure decreased during pegloticase therapy in chronic kidney disease (CKD) and non-CKD patients. There is a significant association between inflammatory bowel disease, particularly Crohn’s disease, and gout. Tophi, as detected by ultrasound, was independently associated with impaired kidney function. Patients with gout and type 2 diabetes found that SGLT2is reduced gout flares, gout-related ED visits, and hospitalizations. The risk of gout flares is influenced by both higher baseline serum urate levels and a greater decrease in serum urate. Assessing the efficacy and safety of pegloticase in adult kidney transplant recipients with uncontrolled gout. Asymptomatic hyperuricemia is independently associated with an increased risk of developing kidney stones. Combining iodinated contrast medium with DECT enhanced the detection of monosodium urate crystals in gout. YouTube videos offering dietary recommendations for patients with gout often diverge from evidence-based guidelines. COVID-19 vaccination was linked to increased early gout flares in patients with infrequent previous flare episodes.